Pallone Unveils Measure to Revamp FDA Accelerated Approval Program
- March 11, 2022
A new measure introduced in the House this week would revamp the Food and Drug Administration’s (FDA’s) accelerated approval program for innovative drugs to ensure they are providing a proven clinical benefit to patients.
ARTICLE TAGS
You must be logged in to access this content.